Ascentage Pharma Group International
AAPG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002023311
No open-market purchases or sales by Ascentage Pharma Group International insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $263.5K in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Ascentage Pharma Group International changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 6 | 12 | +6 |
| Shares | 237.2K | 81.8K | −155.4K (−65.5%) |
| Value | $5.21M | $3.22M | −$1.99M (−38.2%) |
New holders (9)
Institutions that held Ascentage Pharma Group International at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NEOS Investment Management LLC | 15,495 | $610.1K | 0.01% |
| Tema ETFs LLC | 15,495 | $610.1K | 0.16% |
| HSBC Holdings PLC | 9,933 | $391.3K | 0.00% |
| Chevy Chase Trust Holdings, Inc. | 5,753 | $226.5K | 0.00% |
| Morgan Stanley | 956 | $37.6K | 0.00% |
| JPMorgan Chase & Co | 211 | $8.31K | 0.00% |
| Bell Investment Advisors, Inc | 67 | $2.64K | 0.00% |
| EverSource Wealth Advisors, LLC | 24 | $945 | 0.00% |
| Royal Bank of Canada | 6 | $0 | 0.00% |
Sold out (3)
Institutions that held Ascentage Pharma Group International at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Monashee Investment Management LLC | 159,942 | $3.51M |
| Voloridge Investment Management, LLC | 15,943 | $349.9K |
| Verition Fund Management LLC | 9,922 | $217.8K |